Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Braxia Scientific Corp BRAXF


Primary Symbol: C.BRAX

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP... see more

Recent & Breaking News (CSE:BRAX)

New Psychedelics Stocks and Acquisitions

Omri Wallach June 8, 2020

REPEAT - Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

GlobeNewswire June 8, 2020

Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

GlobeNewswire June 8, 2020

Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services

GlobeNewswire May 29, 2020

REPEAT - Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors

GlobeNewswire May 25, 2020

Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors

GlobeNewswire May 25, 2020

REPEAT - Champignon Sponsors Non-profit Coalition, TheraPsil - Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals

GlobeNewswire May 19, 2020

Champignon Sponsors Non-profit Coalition, TheraPsil - Medical Psilocybin Access Project for Palliative Cancer Patients and Health Professionals

GlobeNewswire May 18, 2020

IIROC Trade Resumption - SHRM

Canada NewsWire May 15, 2020

IIROC Trading Halt - SHRM

Canada NewsWire May 15, 2020

Champignon Expands to U.S., To Acquire California Based Ketamine Centre - Wellness Clinic of Orange County

GlobeNewswire May 12, 2020

IIROC Trade Resumption - SHRM

Canada NewsWire May 12, 2020

Champignon Announces $10,000,000 Bought Deal Private Placement

Canada NewsWire May 11, 2020

IIROC Trading Halt - SHRM

Canada NewsWire May 11, 2020

REPEAT - Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer

GlobeNewswire May 11, 2020

Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer

GlobeNewswire May 11, 2020

The StockTalk Cannabis Report: May 8, 2020

Dave Jackson May 8, 2020

REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors

GlobeNewswire May 6, 2020

Champignon Appoints Pat McCutcheon to Board of Directors

GlobeNewswire May 6, 2020

The Impressive Rise of Psychedelics Stocks

Omri Wallach May 4, 2020